NCT01548001 - Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis | Biotech Hunter

Enrollment

910

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Iguratimod

25 mg/tablet, taken orally, 2 tablets/day (bid)

DRUG

Methotrexate

2.5 mg/tablet, taken orally once a week, 4 tablets/week (week 1-week 4) , 6 tablets/week (week 5- week 52)

Trial Locations (1)

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai